Skip to main content

Heron Therapeutics, Inc 10-Q for FY2025 Q2

Heron Therapeutics, Inc. (HRTX)

10-Q 2025-08-08 For: 2025-06-30
View Original
Added on April 09, 2026

About this 10-Q

Heron Therapeutics, Inc filed this 10-Q on August 8, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$37.2M
up 3.3% from $36.02M a year earlier
Net loss
$2.38M
compared with a net loss of $9.24M a year earlier
Diluted EPS
-$0.02
compared with -$0.06 a year earlier